Work

CXCR4 Inhibition with BL-8040 in Combination with Nelarabine in Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia / Lymphoblastic Lymphoma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127121

Authors: Geoffrey L. Uy, Tapan M. Kadia, Wendy Stock, Jonathan E Brammer, Osnat Bohana-Kashtan, Abi Vainstein, Ella Sorani, Hemda Chen, John F. DiPersio, Daniel C. Link

Institutions: Washington University in St. Louis, The University of Texas MD Anderson Cancer Center, University of Chicago, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, BioLineRx Ltd. (Israel)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2987827162

Cites:

Cited by: 9

Related to: 10